2026 Annual Meeting | N5 - Neuroscience in the Clinic: Circadian Neuroscience: Biological Timing Matters in Neurology
| 01:00 PM - 01:05 PM CDT | Introduction |
Introduction
Roneil Malkani, MD, FAAN |
| 01:05 PM - 01:10 PM CDT | Speaker |
Case Presentation
|
| 01:10 PM - 01:35 PM CDT | Speaker |
Clocks, Sleep, and Risk of Neurologic Disease
Amita Sehgal, PhD |
| 01:35 PM - 02:00 PM CDT | Speaker |
Circadian Rhythm Disruption in Neurodegeneration: Mechanisms, Evaluation, and Circadian-based Therapeutic Approaches
Aleksandar Videnovic, MD, MSc, FAAN |
| 02:00 PM - 02:25 PM CDT | Speaker |
Circadian Rhythm Disruption in Headache: Mechanisms, Evaluation, and Circadian-based Therapeutic Approache
Rachel Darken, MD, PhD, FAAN |
| 02:25 PM - 02:35 PM CDT | Speaker |
Abstract Presentation #1
|
| 02:35 PM - 02:45 PM CDT | Speaker |
Abstract Presentation #2
|
| 02:45 PM - 03:00 PM CDT | Q&A |
Case Follow-up and Q&A
Roneil Malkani, MD, FAAN, Phyllis C. Zee, MD, PhD, Rachel Darken, MD, PhD, FAAN, Aleksandar Videnovic, MD, MSc, FAAN, Amita Sehgal, PhD |
| Roneil Malkani, MD, FAAN | Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Author with 好色先生. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Weston Family Foundation. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Consultant with American Academy of Sleep Medicine. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Honoraria with AANI. Dr. Malkani has a non-compensated relationship as a Board Member with Illinois Sleep Society that is relevant to AAN interests or activities. Dr. Malkani has a non-compensated relationship as a Review editor on editorial board with Frontiers that is relevant to AAN interests or activities. |
| Phyllis C. Zee, MD, PhD | Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apnimed. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Caremark. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Biosciences. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals Inc.. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apnimed. Dr. Zee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for World Sleep Society. Dr. Zee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Brain Foundation. An immediate family member of Dr. Zee has stock in Teva. An immediate family member of Dr. Zee has stock in Pfizer. The institution of Dr. Zee has received research support from National Institutes of Health. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received publishing royalties from a publication relating to health care. |
| Rachel Darken, MD, PhD, FAAN | Dr. Darken has nothing to disclose. |
| Aleksandar Videnovic, MD, MSc, FAAN | Dr. Videnovic has nothing to disclose. |
| Amita Sehgal, PhD | No disclosure on file |